BA
ANGO icon

BlackRock Advisors’s AngioDynamics ANGO Stock Holding History

BlackRock Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$250K Sell
14,822
-17,136
-54% -$286K ﹤0.01% 2595
2016
Q3 		$561K Sell
31,958
-189
-0.6% -$3.06K ﹤0.01% 2117
2016
Q2 		$462K Sell
32,147
-27,994
-47% -$350K ﹤0.01% 2158
2016
Q1 		$739K Sell
60,141
-98
-0.2% -$1.08K ﹤0.01% 1892
2015
Q4 		$731K Buy
60,239
+42,845
+246% +$528K ﹤0.01% 1891
2015
Q3 		$229K Buy
17,394
+140
+0.8% +$2.11K ﹤0.01% 2644
2015
Q2 		$283K Buy
17,254
+1,345
+8% +$22.3K ﹤0.01% 2584
2015
Q1 		$283K Buy
15,909
+2,040
+15% +$37.9K ﹤0.01% 2477
2014
Q4 		$264K Sell
13,869
-596
-4% -$10.1K ﹤0.01% 2448
2014
Q3 		$198K Sell
14,465
-224
-2% -$3.2K ﹤0.01% 2618
2014
Q2 		$240K Sell
14,689
-2,053
-12% -$29.7K ﹤0.01% 2522
2014
Q1 		$264K Buy
16,742
+466
+3% +$7.59K ﹤0.01% 2488
2013
Q4 		$279K Buy
16,276
+1,254
+8% +$19.3K ﹤0.01% 2442
2013
Q3 		$198K Sell
15,022
-992
-6% -$11.7K ﹤0.01% 2555
2013
Q2 		$181K Buy
+16,014
New +$170K ﹤0.01% 2529

Other funds holding ANGO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's ANGO Position: Q4 2016 in Review

BlackRock Advisors reduced its AngioDynamics (ANGO) stake by 54% in Q4 2016, selling an estimated $286K and leaving 14,822 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

BlackRock Advisors first reported a position in ANGO in Q2 2013 and has held it in 15 quarters since. The position peaked at $739K in Q1 2016. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.

  • BlackRock Advisors held 14,822 shares of AngioDynamics worth $250K as of Q4 2016.
  • BlackRock Advisors sold 17,136 AngioDynamics shares in Q4 2016, an estimated $286K.
  • AngioDynamics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2595 holding.
  • BlackRock Advisors first reported a position in AngioDynamics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's AngioDynamics position peaked at $739K in Q1 2016.
  • 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.